| Literature DB >> 28078283 |
Danyang Zhao1, Yu Wang2, Dong Han1.
Abstract
The treatment of bone defects is challenging and controversial. As a new technology, periosteal distraction osteogenesis (PDO) uses the osteogenicity of periosteum, which creates an artificial space between the bone surface and periosteum to generate new bone by gradually expanding the periosteum with no need for corticotomy. Using the newly formed bone of PDO to treat bone defects is effective, which can not only avoid the occurrence of immune-related complications, but also solve the problem of insufficient donor. This review elucidates the availability of PDO in the aspects of mechanisms, devices, strategies, and measures. Moreover, we also focus on the future prospects of PDO and hope that PDO will be applied to the clinical treatment of bone defects in the future.Entities:
Mesh:
Year: 2016 PMID: 28078283 PMCID: PMC5203878 DOI: 10.1155/2016/2075317
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1The mechanism (a) and devices (b, c, d) of PDO. (a) PDO creates an artificial space between the bone surface and periosteum to generate new bone by expanding the periosteum, muscle, and skin at the same time. (b) U-shaped distractor composes of three different parts: fixation frame, distraction rod, and titanium mesh. Bilateral fixation legs can be fixed rigidly to the surface of cortical bone by titanium screws, and then through the rotation of middle distraction rod, the titanium mesh can be lifted off the ground of bone and distract the periosteum simultaneously. (c) SMA leaves out distraction screws. (d) Biodegradable PLLA/HA mesh instead of titanium mesh for distracting periosteum.
Summary of preclinical animal experiments.
| Authors | Distractor | Animal | Position | Latency period | Distraction period | Consolidation period | Factor | Year | Reference number |
|---|---|---|---|---|---|---|---|---|---|
| Kostopoulos and Karring | PTFE capsule | Rat | Mandibular ramus | 0 days | Immediate distraction | 7, 14 days and 1, 2, 4 weeks | Different opening direction | 1995 | [ |
|
| |||||||||
| Schmidt et al. | Titanium mesh | Rabbit | Lateral surface of the mandible | 7 days | 7 mm over 15 days | Days 28, 35, 42, 56 | None | 2002 | [ |
|
| |||||||||
| Stevens et al. | Calcium-alginate gel | Rabbit | Anteromedia aspect of metaphyseal and diaphyseal tibia | 0 days | Immediate distraction | 6, 8, 12 weeks | TGF- | 2005 | [ |
|
| |||||||||
| Kessler et al. | Titanium mesh | Minipig | Forehead region | 5 days | 0.5 mm/d for 10 days | 7, 17, 45 days | In comparison with IE | 2007 | [ |
|
| |||||||||
| Sencimen et al. | Stainless steel device | Rabbit | Lateral surface of the mandible | 7 days | 0.25 mm twice a day for 10 days | 15, 30, 60 days | In comparison with DO | 2007 | [ |
|
| |||||||||
| Estrada et al. | Plate supported by a screw | Rabbit | Forehead | 10 days | 0.25 mm/d or 0.5 mm/d until 8 mm | 10, 20, 30, 40, 50, 60 days after distraction | Different distraction rates | 2007 | [ |
|
| |||||||||
| Estrada et al. | Distraction rod with basel staple and titanium plate | Dog | Intraoral in the four quadrants | 10 days | 0.22 mm/d for 22 days | 90 days | None | 2007 | [ |
|
| |||||||||
| Yamauchi et al. | Highly purified | Dog | Lateral surface of the mandible | 8 days | 0.5 mm/d for 8 days | 8 weeks | None | 2008 | [ |
|
| |||||||||
| Casap et al. | U-shaped device Made of stainless steel and titanium | Rabbit | Mandible | 2 weeks | 1 mm/d for 7 days | 60 days | VEGF | 2008 | [ |
|
| |||||||||
| Abrahamsson et al. | Osmotic self-inflatable expander | Rabbit | Lower border of the mandible | 0 days | Depend on the inflation rate of the expander | 2 weeks | None | 2009 | [ |
|
| |||||||||
| Oda et al. | Titanium mesh | Rabbit | Mandible | 7 days | 0.5 mm/d for 8 days | 4 and 8 weeks | Cortical bone perforation | 2009 | [ |
|
| |||||||||
| Lethaus et al. | Laser-perforated titanium | Minipig | Forehead region | 3 days | 0.5 mm twice per day for periods 5, 10, 15 days, respectively | 14, 28, 42 days | Versus static shielding | 2010 | [ |
|
| |||||||||
| Sato et al. | Mesh plate | Rabbit | Parietal bone | 7 days | 20 days | 3 weeks | Bone marrow stem cell administration | 2010 | [ |
|
| |||||||||
| Altuğ et al. | U-shaped distractor built from stainless steel | Rabbit | Lateral aspect of the mandible | 1 day or 7 days | 0.25 mm twice a day for 10 days | 15, 30, 60 days | Different latency periods | 2011 | [ |
|
| |||||||||
| Zakaria et al. | Biodegradable mesh (PLLA/HA) | Rabbit | Calvarial bone | 7 days | 0.5 mm every 12 hours for 5 days | 4 and 6 weeks | Different distraction rates | 2012 | [ |
|
| |||||||||
| Zakaria et al. | Titanium mesh | Rabbit | Calvarial bone | 7 days | 0.5 mm every 12 hours for 5 days | 4 and 6 weeks | Different distraction rates | 2012 | [ |
|
| |||||||||
| Saulacic et al. | Hemispherical disc | Rat | Calvarial bone | 7 days | 0.4 mm/d for 10 days | 10, 20 days | None | 2013 | [ |
|
| |||||||||
| Saulacic et al. | Occlusive distraction plate or perforation of the distraction plate | Rat | Calvaria | 7 days | 0.2 mm/d for 10 days | 7 days | Different distractors | 2013 | [ |
|
| |||||||||
| Yamauchi et al. | Ni-Ti SMA | Rabbit | Forehead | 14 days | Depend on the elasticity of SMA | 3 and 6 weeks | None | 2013 | [ |
|
| |||||||||
| Suer et al. | Custom-design device | Rabbit | Lateral surface of the mandibular corpus | 7 days | 0.25 mm Twice a day for 6 days | 4 and 8 weeks | HBO | 2014 | [ |
|
| |||||||||
| Kahraman et al. | A new periosteal distractor | Rabbit | Periosteumeum at the forehead | 7 days | 0.35 mm/d for 10 days, 45 days | Simvastatin | 2015 | [ | |
|
| |||||||||
| Pripatnanont et al. | Modified Hyrax device | Rabbit | Ramus and body of mandible | 3 days | 0.5 mm twice a day for 7 days | 4 and 8 weeks | PRF | 2015 | [ |
|
| |||||||||
| Saulacic et al. | Custom made distraction device | Rabbit | Calvaria | 7 days | 0.25 or 0.5 mm/d for 10 days | 1 week, 2 weeks, 2 months | Different distraction rates | 2016 | [ |
|
| |||||||||
| Dziewiecki et al. | Nondegradable titanium device and degradable devices (poly-DL-lactide and polyglycolic acid) | Minipig | Calvarial bone | 0 days | Immediate distraction | 12, 28, 42 days | None | 2016 | [ |
|
| |||||||||
| Yamauchi et al. | SMA mesh device and absorbable thread | Rabbit | Under the periosteum at the forehead | 0 days | Time-released dynamic distraction | 4 and 8 weeks | None | 2016 | [ |
IE = Immediate Elevation; DO = distraction osteogenesis; SMA = self-activated memory alloy; HBO = hyperbaric oxygen; PRF = platelet-rich fibrin; PTFE = Polytetrafluoroethylene; TGF-β = transforming growth factor-β; FGF-2 = fibroblast growth factor-2.
Figure 2Protocol of PDO applied in different studies. The latency periods of PDO are different from 0 days to 14 days, the distraction periods of PDO are different from 0 days to 32 days, and the speed is 0.2–1.0 mm/d; the consolidation periods of PDO are different from 1 week to 3 months.